Search results
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip By Investing.com
Investing.com· 2 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 3 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
2021: The Brave New Normal
New Jersey Business Magazine· 6 days agoAs James W. Hughes, Ph.D., dean emeritus of the Edward J. Bloustein School of Planning and Public Policy at Rutgers University, says, “COVID-19 has...
FDA finalizes lab test regulations with more flexibility
Politico· 1 day ago“It’s a shame that an administration committed to ending cancer as we know it has retreated from this critical public health strategy,” Senate Majority Whip Dick Durbin (D ...
